LILRB1, also known as CD85j and ILT2, is a 110 kDa transmembrane glycoprotein in the LILR immunoregulatory protein family. Mature human LILRB1 consists of a 438 amino acid (aa) extracellular domain (ECD) with 4 tandem Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 4 inhibitory ITIM motifs.LILRB1 is a receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles. Receptor for H301/UL18, a human cytomegalovirus class I MHC homolog. Ligand binding results in inhibitory signals and down-regulation of the immune response.
95 % as determined by Tris-Bis PAGE, 95 % as determined by HPLC.
Target:
Rhesus macaque LILRB1/CD85j/ILT2
Application Notes:
Cross-Reactivity: Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage,it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA,5% HSA,10% FBS or 5% Trehalose),and aliquot the reconstituted protein solution to minimize free-thaw cycles., ResearchArea: Other Recombinant Protein
Recombinant Rhesus macaque LILRB1/ILT-2/CD85j Protein was determined by Tris-Bis PAGE under reducing conditions.
The purity of Rhesus macaque LILRB1/CD85j/ILT2 is greater than 95% as determined by SEC-HPLC.
Anti-LILRB1 Antibody, hFc Tag captured on CM5 Chip via Protein A can bind Rhesus macaque LILRB1, His Tag with an affinity constant of 215.30 nM as determined in SPR assay (Biacore T200).
* VAT and and shipping costs not included. Errors and price changes excepted
